{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:31:22Z","timestamp":1781523082155,"version":"3.54.1"},"reference-count":30,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2002,1,5]],"date-time":"2002-01-05T00:00:00Z","timestamp":1010188800000},"content-version":"vor","delay-in-days":1131,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:p><jats:sc>objective<\/jats:sc>\u2002To determine the effects of ivermectin in annual, 3\u2010monthly and 6\u2010monthly doses on onchocercal skin disease (OSD) and severe itching.<\/jats:p><jats:p><jats:sc>method<\/jats:sc>\u2002A multicentre, double\u2010blind placebo controlled trial was conducted among 4072 residents of rural communities in Ghana, Nigeria and Uganda. Baseline clinical examination categorized reactive skin lesions as acute papular onchodermatitis, chronic papular onchodermatitis and lichenified onchodermatitis. Presence and severity of itching was determined by open\u2010ended and probing questions. Clinical examination and interview took place at baseline and each of 5 subsequent 3\u2010monthly follow\u2010up visits.<\/jats:p><jats:p><jats:sc>results<\/jats:sc>\u2002While prevalence and severity of reactive lesions decreased for all 4 arms, those receiving ivermectin maintained a greater decrease in prevalence and severity over time. The difference between ivermectin and placebo groups was significant for prevalence at 9 months and for severity at 3 months. Differences between placebo and ivermectin groups were much more pronounced for itching. From 6 months onward, the prevalence of severe itching was reduced by 40\u201350% among those receiving ivermectin compared to the trend in the placebo group.<\/jats:p><jats:p><jats:sc>conclusion<\/jats:sc>\u2002This is an important effect on disease burden as severe itching is for the affected people the most troubling complication of onchocerciasis. The difference among regimens was not significant, and the recommended regimen of annual treatment for the control of ocular onchocerciasis appears also the most appropriate for onchocerciasis control in areas where the skin manifestations predominate. The final determination of the effect on skin lesions requires a longer period of study.<\/jats:p>","DOI":"10.1046\/j.1365-3156.1998.00339.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:30:44Z","timestamp":1047504644000},"page":"951-961","source":"Crossref","is-referenced-by-count":53,"title":["The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial"],"prefix":"10.1111","volume":"3","author":[{"family":"Brieger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Awedoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Eneanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ogbuagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Okello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ososanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ovuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Noma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Remme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,5]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90002-X"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(94)90172-4"},{"key":"e_1_2_6_4_2","first-page":"322","article-title":"Detrimental effects of onchocerciasis on marriage and breastfeeding.","volume":"46","author":"Amazigo UO","year":"1994","journal-title":"Tropical and Geographical Medicine"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(97)90406-5"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(98)00007-0"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.52-270"},{"key":"e_1_2_6_8_2","unstructured":"African Program for Onchocerciasis Control: Program Document. The World Bank Washington."},{"key":"e_1_2_6_9_2","first-page":"229","article-title":"Impact of annual dosing with ivermectin on progression of onchocercal visual field loss.","volume":"75","author":"Cousens S","year":"1997","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(91)90051-Y"},{"key":"e_1_2_6_11_2","first-page":"54","article-title":"Studies on the types and distribution patterns of blackflies (Simulium species) in Anambra State,","volume":"1","author":"Iwuala MOE","year":"1980","journal-title":"Nigeria. Nigerian Journal of Parasitology"},{"key":"e_1_2_6_12_2","unstructured":"Cost\u2010Benefit Analysis of the Onchocerciasis Control Program (OCP) Technical Paper no. 282. The World Bank Washington."},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/00494755920220S109"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb11844.x"},{"key":"e_1_2_6_15_2","unstructured":"A Manual for Rapid Epidemiological Mapping of Onchocerciasis. World Health Organization Geneva."},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-3156.1997.tb00148.x","article-title":"Farm land size and onchocerciasis status of peasant farmers in southwestern Nigeria.","volume":"2","author":"Oladepo O","year":"1997","journal-title":"Tropical Medicine & International Health"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/her\/9.4.507"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90634-A"},{"key":"e_1_2_6_19_2","unstructured":"Special Programme for Research and Training in Tropical Diseases TDR\/AFR\/RP\/95.1. UNDP\/World Bank\/WHO Geneva"},{"key":"e_1_2_6_20_2","first-page":"367","article-title":"A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of","volume":"40","author":"Remme J","year":"1989","journal-title":"Onchocerca volvulus. Tropical Medicine and Parasitology"},{"key":"e_1_2_6_21_2","unstructured":"The global epidemiology of infectious diseases. (eds. CJL Murray & A Lopez) Harvard University Press Cambridge in press."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1993.48.9"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2218502"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(91)90236-R"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(92)90309-Z"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(92)90308-Y"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.1996.tb00111.x"},{"key":"e_1_2_6_28_2","unstructured":"WHO Technical Report Series852."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0001-706X(93)90054-F"},{"key":"e_1_2_6_30_2","unstructured":"Strategies for Ivermectin Distribution through Primary Health Care Systems. Programme for the Prevention of Blindness WHO\/PBL\/91.24. WHO Geneva"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1971.11686785"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3156.1998.00339.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.1998.00339.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-3156.1998.00339.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.1998.00339.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T01:11:13Z","timestamp":1704589873000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3156.1998.00339.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1046\/j.1365-3156.1998.00339.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3156.1998.00339.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}